Open AccessAn update on the diagnostic biomarkers for asthma
Author(s) -
Rashmi Pandey,
Ved Parkash,
Surya Kant,
Ajay Kumar Verma,
Satya Narayan Sankhwar,
Avinash Aujayeb,
Devendra Parmar,
Sheetal Verma,
Kaleem Ahmad
Publication year - 2021
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_2037_20
Subject(s) - medicine , asthma , wheeze , spirometry , bronchodilator , intensive care medicine , diagnostic test , pathophysiology of asthma , bronchodilator agents , pediatrics
Asthma is a respiratory disorder accounts for ~339 million cases per annum. The initial diagnosis of asthma relies on the symptomatic identification of characters, such as wheeze, shortness of breath, chest tightness, and cough. The presence of two or more of these symptoms may be considered as indicative of asthma. The asthma-diagnostic also involves spirometry test before and after inhaling a bronchodilator like albuterol. Because asthma pathophysiology involves participation of immune system, the cytokines play an important role. The review discusses various molecules that are or may be used as biomarkers for the asthma diagnosis.